AeroSafe Global

About:

AeroSafe Global develops aerogels used in various transport, biomedical, pharmaceutical, and other temperature-sensitive products.

Website: https://www.aerosafeglobal.com/

Twitter/X: AeroSafeGlobal

Top Investors: NewSpring, Hamilton Lane, Cycle Capital, Merck Global Health Innovation Fund, Escalate Capital Partners

Description:

AeroSafe Global develops and produces aerogels and related materials for temperature-sensitive shipping needs in the United States. Its products are used in various thermal insulation applications to transport biomedical, pharmaceutical, and other temperature-sensitive products. The company provides a reliable, simple, and sustainable temperature sensitive supply chain solutions to the world’s leading biopharma companies. AeroSafe Global delivers cold-chain services for the biopharma industry that results in zero temperature excursions for every client, every product, every time. With proprietary packaging, logistics, and operational services, the company builds customized solutions that ensure the safe delivery of temperature-sensitive biopharmaceuticals.

Total Funding Amount:

$163M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Rochester, New York, United States

Founded Date:

1995-01-01

Contact Email:

info(AT)americanaerogel.com

Founders:

Robert Mendenhall

Number of Employees:

51-100

Last Funding Date:

2023-08-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai